Tharimmune files 1-for-25 reverse stock split effective Nov 20 to meet Nasdaq's $1.00 bid price

Canton Strategic Holdings, Inc.

Reverse split ratio 1-for-25, effective Nov 20 at 4:01 pm ET; trading on post-split basis Nov 21 under THAR.
After split, approximately 700,474 shares of common stock outstanding.
Split approved by stockholders on Oct 23; final ratio set by the Board of Directors.
Primary purpose: regain compliance with Nasdaq's $1.00 minimum bid price for continued listing.
Fractional shares will be rounded up to the next whole share; proportionate adjustment to equity awards.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Canton Strategic Holdings, Inc.: Filing of Certificate of Amendment to effect a 1-for-25 reverse stock split (effective 2023-11-20).

Change: charter amendment
Effective: 2023-11-20

Exact text from the filing

On November 17, 2023, Tharimmune, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to its Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware pursuant to which it effected a 1-for-25 reverse stock split of its issued and outstanding shares of common stock (the “Reverse Split”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Canton Strategic Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-041873

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.